Medical Insights from Industry

RSS
"Insights from Industry" is a dynamic series of interviews at the cutting edge of the medical industry. Every interviewee is a leader in their particular field and is handpicked to give an informative and accessible insight into their chosen field. These interviews are guaranteed to keep you in the know in a rapidly changing industry.
Pneumococcal vaccine: an interview with Graham Clarke, CEO ImmBio

Pneumococcal vaccine: an interview with Graham Clarke, CEO ImmBio

Ulcerative colitis and Crohn’s disease treatments: an interview with Dr Parikh, vice president, general medicine, Takeda

Ulcerative colitis and Crohn’s disease treatments: an interview with Dr Parikh, vice president, general medicine, Takeda

Handheld ultrasound devices: an interview with Warren Ortmann, Signostics

Handheld ultrasound devices: an interview with Warren Ortmann, Signostics

Biological markers for triple-negative breast cancer (TNBC): an interview with Alexandre Templier, CEO of Quinten

Biological markers for triple-negative breast cancer (TNBC): an interview with Alexandre Templier, CEO of Quinten

Hepatitis C and HIV co-infection treatment: an interview with Prof Boecher, Boehringer Ingelheim

Hepatitis C and HIV co-infection treatment: an interview with Prof Boecher, Boehringer Ingelheim

Tivozanib: an interview with Stephen L. Eck, M.D., Ph.D., Vice President, Global Oncology, Astellas Pharma US, Inc. Global Development

Tivozanib: an interview with Stephen L. Eck, M.D., Ph.D., Vice President, Global Oncology, Astellas Pharma US, Inc. Global Development

Non-surgical weight loss devices: an interview with Richard Thompson, CEO ReShape Medical

Non-surgical weight loss devices: an interview with Richard Thompson, CEO ReShape Medical

Non-invasive prenatal genetic screening: an interview with Dr. Charles Strom, Senior Medical Director, Quest Diagnostics

Non-invasive prenatal genetic screening: an interview with Dr. Charles Strom, Senior Medical Director, Quest Diagnostics

Anti-cancer drug conjugates: an interview with Dr Andreas Menrad, CSO Ablynx and Dr Chris Martin, CEO Spirogen

Anti-cancer drug conjugates: an interview with Dr Andreas Menrad, CSO Ablynx and Dr Chris Martin, CEO Spirogen

Medical Adhesives for Reusable or Disposable Medical Devices

Medical Adhesives for Reusable or Disposable Medical Devices

Breast cancer tests: an interview with Dr Steven Quay, CEO of Atossa Genetics

Breast cancer tests: an interview with Dr Steven Quay, CEO of Atossa Genetics

Antibody-drug conjugates (ADCs): an interview with Dr Marco Timmers, CSO at Synthon Biopharmaceuticals

Antibody-drug conjugates (ADCs): an interview with Dr Marco Timmers, CSO at Synthon Biopharmaceuticals

Otolaryngology, head and neck surgery: an interview with Thomas Cherry, Cook Medical

Otolaryngology, head and neck surgery: an interview with Thomas Cherry, Cook Medical

Metastatic renal cell carcinoma (mRCC) therapy: an interview with Charles A. Nicolette, Ph.D., CSO of Argos Therapeutics

Metastatic renal cell carcinoma (mRCC) therapy: an interview with Charles A. Nicolette, Ph.D., CSO of Argos Therapeutics

Finding medical applications for unused inventions: an interview with Gabriel Mecklenburg, Co-Founder of Marblar

Finding medical applications for unused inventions: an interview with Gabriel Mecklenburg, Co-Founder of Marblar

Neuromuscular blockade (NMB) reversal

Neuromuscular blockade (NMB) reversal

Macular pigment screening: an interview with Jaquie Finn, Product Line Manager at Elektron Technology

Macular pigment screening: an interview with Jaquie Finn, Product Line Manager at Elektron Technology

Dementia diagnosis: an interview with Dr Andrew Blackwell, Chief Scientific Officer, Cambridge Cognition

Dementia diagnosis: an interview with Dr Andrew Blackwell, Chief Scientific Officer, Cambridge Cognition

Regenerative medicine: an interview with Christophe Dardel, President of DSM Biomedical

Regenerative medicine: an interview with Christophe Dardel, President of DSM Biomedical

Exoskeleton technology: an interview with Larry Jasinski, CEO, ARGO Medical Technologies

Exoskeleton technology: an interview with Larry Jasinski, CEO, ARGO Medical Technologies